Trials

Interim Data From Peregrine's Phase II Trial in Second-Line Non-Small Cell Lung Cancer Demonstrate Doubling of Median Overall Survival in Bavitiximab-Containing Arms

TUSTIN, CA: TUSTIN, CA -- (Marketwire) -- 09/07/12 --Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), today announced that interim results were presented from its 121 patient randomized, double-blind, placebo-cont ...

Boston Therapeutics Reports Second Quarter and Six Months 2012 Financial Results

MANCHESTER, NH: Initiated launch of SUGARDOWN(R) in the U.S. at the Endocrinology Annual Meeting; SUGARDOWN(R) Sales Increased 845% in the First Half of 2012; Completed Patient Enrollment for Phase II PAZ320 Clinical ...

Agennix AG Reports Financial Results for Second Quarter and First Half of 2012

PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX: PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX -- (Marketwire) -- 07/31/12 -- Agennix AG (FRANKFURT: AGX) (XETRA: AGX), a biopharmaceutical company focused on developing novel ...

Full Spectrum Genetics and BioBlocks Enter Collaboration to Discover Novel Small Molecule Therapeutics That Inhibit a Commercially Validated Cancer Target

SOUTH SAN FRANCISCO, CA and SAN DIEGO, CA: SOUTH SAN FRANCISCO, CA and SAN DIEGO, CA -- (Marketwire) -- 06/13/12 -- Full Spectrum Genetics, Inc., a privately-held biopharmaceutical company, and BioBlocks, Inc., a privately-held small molecul ...

Cromos(TM) Pharma Announces Participation in ASCO 2012 on June 1-5 in Chicago, IL

LONGVIEW, WA: LONGVIEW, WA -- (Marketwire) -- 05/24/12 -- Cromos™ Pharma, a full service, regional Contract Research Organization (CRO), announced today that it will participate and exhibit at the Annual Meetin ...

Agile Therapeutics President and Chief Executive Officer Al Altomari Is an Ernst & Young Entrepreneur Of The Year(R) 2012 Finalist in New Jersey

PRINCETON, NJ: PRINCETON, NJ -- (Marketwire) -- 05/15/12 -- Agile Therapeutics today announced that President and Chief Executive Officer Al Altomari was named a finalist in the Ernst & Young Entrepreneur Of T ...

Agennix AG Reports Financial Results for First Quarter of 2012

PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX: Provides Update on Lead Product Candidate, Oral Talactoferrin ...

Researchers at DSMZ Develop Innovative Software for Biolog Phenotypic Analyses to Improve Our Understanding of the Metabolic Processes of Microorganisms and Other Cells

HAYWARD, CA: HAYWARD, CA -- (Marketwire) -- 04/27/12 -- An interdisciplinary team of microbiologists, plant bioengineers and bioinformatics experts of the Leibniz Institute DSMZ - German Collection of Microorgan ...

Cytokinetics Announces CK-2017357 Receives Fast Track Designation From the FDA for the Potential Treatment of Amyotrophic Lateral Sclerosis

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 04/19/12 -- Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that CK-2017357, its fast skeletal muscle troponin activator, has received Fast Track ...

Biolog Announces Appointment of Distributors in Europe

HAYWARD, CA: HAYWARD, CA -- (Marketwire) -- 03/29/12 -- New distributors were announced today by Biolog, Inc. to cover sales and marketing of its innovative product lines for characterization and identification ...